You are currently viewing a new version of our website. To view the old version click .

Rare Neurological Diseases

This special issue belongs to the section “Medical Research“.

Special Issue Information

Dear Colleagues,

In Europe, a rare disease is one that affects fewer than 5 people per 10,000 in the population. This low prevalence results in a relatively low interest in investing in research into these diseases and the development of therapies. Nevertheless, they exist. More than 7000 rare diseases are supposed to exist, and a relevant group are neurological disorders: inherited retinal dystrophies, epilepsies, ataxias, choreas, dystonias, etc. Most of them are Mendelian disorders, affect children, are congenital, and may cause severe disability. They are often chronic and life-threatening. To make things worse, most of them lack an effective treatment. In this Special Issue, we invite you to submit original articles, reviews, or case reports focused on how neurodegeneration is commonly involved in the pathomechanisms of many rare diseases, and the most recent advances that may enable patients to receive an accurate diagnosis and achieve a rational treatment.

Dr. Carmen Espinós
Dr. Máximo Ibo Galindo
Dr. Regina Rodrigo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Rare diseases
  • Neurodegeneration
  • Genetics
  • Omics
  • Biomarkers
  • Drug discovery
  • Cell therapy
  • Pharmacological therapy
  • Genomic edition
  • Clinical trials

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Life - ISSN 2075-1729